| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -8.85M | -56.96% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 05Y.F returned -26.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -25.3% |
| 1 year | -26.8% |
| 5 years | -94.6% |
| 10 years | -94.4% |
| All-time high | €24.39 (Oct 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 05Y.F would be worth today ›No. Vivoryon Therapeutics N.V. has not paid a dividend in the past 12 months.
Vivoryon Therapeutics N.V. is part of the Healthcare sector.
Vivoryon Therapeutics N.V. has a market cap of 31.84M EUR, based on the latest quote.
Vivoryon Therapeutics N.V. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.